Postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting or cardiac valve surgery: intraoperative use of landiolol
<p>Abstract</p> <p>Background</p> <p>Landiolol hydrochloride is a new β-adrenergic blocker with a pharmacological profile that suggests it can be administered safely to patients who have sinus tachycardia or tachyarrhythmia and who require heart rate reduction. This stu...
Main Authors: | Nakanishi Kazuhiro, Takeda Shinhiro, Kim Chol, Kohda Shusuke, Sakamoto Atsuhiro |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-01-01
|
Series: | Journal of Cardiothoracic Surgery |
Subjects: | |
Online Access: | http://www.cardiothoracicsurgery.org/content/8/1/19 |
Similar Items
-
Landiolol hydrochloride for prevention of atrial fibrillation during esophagectomy: a randomized controlled trial
by: Yoshitaka Aoki, et al.
Published: (2020-05-01) -
Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature
by: Matsuishi Y, et al.
Published: (2020-04-01) -
Prevention of immediate recurrence of atrial fibrillation with low-dose landiolol after radiofrequency catheter ablation
by: Daisuke Ishigaki, M.D., et al.
Published: (2015-10-01) -
Efficacy and safety of cardioversion with continuous landiolol infusion for atrial tachyarrhythmia in an inflammatory state caused by volvulus in a child with TARP syndrome and postoperative tetralogy of Fallot
by: Kenji Miyamoto, et al.
Published: (2018-08-01) -
Practical applicability of landiolol, an ultra-short-acting β1-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction
by: Yuko Wada, et al.
Published: (2016-04-01)